May 24(Reuters) - Healios KK 4593.T
* Says the company has executed the collaborative research
and
development agreement with the National Eye Institute (NEI)
* The scope of this collaboration is the development of an
allogeneic induced pluripotent stem cell (iPSC)-derived retinal
pigment epithelium (RPE) cell therapy for age-related macular
degeneration
Source text in Japanese:https://goo.gl/ihozxA
Further company coverage: 4593.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))